The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Clinical and Neuropathological Features of the Arctic APP Gene Mutation Causing Early-Onset Alzheimer Disease
Open accessAbstract
BACKGROUND: A majority of mutations within the beta-amyloid region of the amyloid precursor protein (APP) gene cause inherited forms of intracerebral hemorrhage. Most of these mutations may also cause cognitive impairment, but the Arctic APP mutation is the only known intra-beta-amyloid mutation to date causing the more typical clinical picture of Alzheimer disease. OBJECTIVE: To describe features of 1 Swedish and 1 American family with the previously reported Arctic APP mutation. DESIGN, SETTING, AND PARTICIPANTS: Affected and nonaffected carriers of the Arctic APP mutation from the Swedish and American families were investigated clinically. In addition, 1 brain from each family was investigated neuropathologically. RESULTS: The clinical picture, with age at disease onset in the sixth to seventh decade of life and dysfunction in multiple cognitive areas, is indicative of Alzheimer disease and similar to the phenotype for other Alzheimer disease APP mutations. Several affected mutation carriers displayed general brain atrophy and reduced blood flow of the parietal lobe as demonstrated by magnetic resonance imaging and single-photon emission computed tomography. One Swedish case and 1 American case with the Arctic APP mutation came to autopsy, and both showed no signs of hemorrhage but revealed severe congophilic angiopathy, region-specific neurofibrillary tangle pathological findings, and abundant amyloid plaques. Intriguingly, most plaques from both of these cases had a characteristic ringlike character. CONCLUSIONS: Overall, our findings corroborate that the Arctic APP mutation causes a clinical and neuropathological picture compatible with Alzheimer disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“To date, 228 PSEN1 mutations have been identified causing ADAD (49, 303, 304, 440, 566, 580).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [49]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“APP mutations can lead to cerebrovascular pathology including BBB breakdown and cerebral amyloid angiopathy (CAA), as shown in humans (49, 211, 356, 674) and transgenic animal models expressing human APP mutations (56, 57, 137, 321, 322, 331, 336, 405, 420, 464, 467, 512, 513, 579, 606).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [49]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Individuals with 'vasculotropic' APP mutations within A 𝛃 21-23 residues including Dutch (E693Q), Arctic (E693G), Flemish (A692G), Iowa (D694N), and Italian (E693K) mutation (49, 211, 335, 356, 526, 674) develop prominent CAA (238, 640) causing extensive cerebrovascular pathology.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CBF reductions have also been reported in humans carrying vasculotropic APP mutations (49).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [49]
The cited source says what the claim attributes to it.
In the citing paper
“Autosomal-dominant AD (ADAD) is an inherited form of AD caused by mutations in amyloid precursor protein ( APP ) and presenilin-1 and 2 ( PSEN1; PSEN2 ) genes (49, 177, 303, 304, 580).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
(1995) · Cited by 2,809
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Self-citationMullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992) · Nature Genetics · doi:10.1038/ng0892-345 · Cited by 1,513
Self-citationBorchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I. M., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,399
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Self-citation
Research works printed but not linked: 2
- [20]Wechsler D. Wechsler Adult Intelligence Scale – Revised: Manual. New York: Psychological Corporation; 1981. [Google Scholar]
- [21]Lezak M. Neuropsychological Assessment. 3rd. New York: Oxford University Press; 1995. [Google Scholar]
Cited by
Sorted by citations
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947
Bateman, R. J., Aisen, P. S., De Strooper, B., Fox, N. C., Lemere, C. A., Ringman, J. M., Salloway, S., Sperling, R. A., Windisch, M., & Xiong, C. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt59 · Cited by 573
The genetics and neuropathology of Alzheimer’s disease
Schellenberg, G. D., & Montine, T. J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0996-2 · Cited by 256
Self-citationEarly-Onset Familial Alzheimer's Disease (EOFAD)
Wu, L., Rosa‐Neto, P., Hsiung, G. R., Sadovnick, A. D., Masellis, M., Black, S. E., Jia, J., & Gauthier, S. G. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013949 · Cited by 240
Chen, T., Dai, Y., Hu, C., Lin, Z., Wang, S., Yang, J., Zeng, L., Li, S., & Li, W. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00557-1 · Cited by 205
Weggen, S., & Beher, D. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt107 · Cited by 192
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
Schöll, M., Wall, A., Thordardottir, S., Ferreira, D., Bogdanovic, N., Långström, B., Almkvist, O., Graff, C., & Nordberg, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31825fdf18 · Cited by 169
Self-citationCorrelating familial Alzheimer’s disease gene mutations with clinical phenotype
Ryan, N. S., & Rossor, M. N. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.92 · Cited by 176
Recent advances in the modeling of Alzheimer’s disease
Sasaguri, H., Hashimoto, S., Watamura, N., Sato, K., Takamura, R., Nagata, K., Tsubuki, S., Ohshima, T., Yoshiki, A., Sato, K., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.807473 · Cited by 157
Passive immunotherapies targeting Aβ and tau in Alzheimer's disease
Plotkin, S. S., & Cashman, N. R. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105010 · Cited by 161
Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update
Yadollahikhales, G., & Rojas, J. C. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01405-0 · Cited by 165
Geng, Y.-T., Li, C., Liu, J., Xing, G., Li, Z., Dong, M., Li, X., & Niu, Y. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.836 · Cited by 129
Variations in the neuropathology of familial Alzheimer’s disease
Shepherd, C. E., McCann, H., & Halliday, G. M. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0521-4 · Cited by 135
Soluble Aβ Promotes Wild-Type Tau Pathology In Vivo
Chabrier, M. A., Blurton-Jones, M., Agazaryan, A. A., Nerhus, J. L., Martinez-Coria, H., & LaFerla, F. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0172-12.2012 · Cited by 123
Cerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.76 · Cited by 122
Manook, A., Yousefi, B. H., Willuweit, A., Platzer, S., Reder, S., Voß, A., Huisman, M. C., Settles, M., Neff, F., Velden, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031310 · Cited by 121
Hereditary Cerebral Hemorrhage With Amyloidosis Associated With the E693K Mutation of APP
Bugiani, O., Giaccone, G., Rossi, G., Mangieri, M., Capobianco, R., Morbin, M., Mazzoleni, G., Cupidi, C., Marcon, G., Gıovagnolı, A. R., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.178 · Cited by 118
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models
Schaeffer, E. L., Figueiró, M., & Gattaz, W. F. (2011) · Clinics · doi:10.1590/s1807-59322011001300006 · Cited by 114
Philipson, O., Hammarström, P., Nilsson, K. P. R., Portelius, E., Olofsson, T., Ingelsson, M., Hyman, B. T., Blennow, K., Lannfelt, L., Kalimo, H., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.022 · Cited by 108
Self-citationAPOE-4 Genotype and Neurophysiological Vulnerability to Alzheimer's and Cognitive Aging
Bookheimer, S. Y., & Burggren, A. C. (2009) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153625 · Cited by 108
Ringman, J. M., Monsell, S., Ng, D. W., Zhou, Y., Nguyen, A., Coppola, G., Van Berlo, V., Mendez, M. F., Tung, S., Weintraub, S., et al. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv028 · Cited by 99
Sex differences in Alzheimer’s disease: Understanding the molecular impact
Toro, C. A., Zhang, L., Cao, J., & Cai, D. (2019) · Brain Research · doi:10.1016/j.brainres.2019.05.031 · Cited by 105
Animal models of amyloid‐β‐related pathologies in Alzheimer’s disease
Philipson, O., Lord, A., Gumucio, A., O'Callaghan, P. W., Lannfelt, L., & Nilsson, L. N. G. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07564.x · Cited by 101
Self-citationUnderstanding the roles of mutations in the amyloid precursor protein in Alzheimer disease
Hunter, S., & Brayne, C. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.218 · Cited by 94
Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
Dominantly Inherited Alzheimer Network, Ringman, J. M., Goate, A., Masters, C. L., Cairns, N. J., Danek, A., Graff-Radford, N., Ghetti, B., & Morris, J. C. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0499-8 · Cited by 96
Yang, Y., Zhang, W., Murzin, A. G., Schweighauser, M., Huang, M., Lövestam, S., Peak‐Chew, S., Saito, T., Saido, T. C., Macdonald, J. A., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-022-02533-1 · Cited by 93
Li, J., Wang, G., Liu, J., Li, Z., Dong, M., Wang, R., Li, X., Li, X., Lin, C., & Niu, Y. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.045 · Cited by 86
Albrecht, S., Bogdanović, N., Ghetti, B. F., Winblad, B. G., & LeBlanc, A. C. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181c1da10 · Cited by 80
Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features
Giaccone, G., Morbin, M., Moda, F., Botta, M., Mazzoleni, G., Uggetti, A., Catania, M., Moro, M. L., Redaelli, V., Spagnoli, A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0747-1 · Cited by 73
Wei, G., Chen, Y., Chen, D., Lai, X., Liu, D., Deng, R., Zhou, J., Zhang, S., Li, Y.-W., Lii, H., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120865 · Cited by 66
Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases
Walker, L. C. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-120215-034943 · Cited by 60
Norlin, N., Hellberg, M., Filippov, A. V., Sousa, A. A., Gröbner, G., Leapman, R. D., Almqvist, N., & Antzutkin, O. N. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.06.010 · Cited by 62
Clinical Genetics of Alzheimer’s Disease
Zou, Z., Liu, C., Che, C., & Huang, H. (2014) · BioMed Research International · doi:10.1155/2014/291862 · Cited by 60
Tomiyama, T., & Shimada, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041413 · Cited by 62
Clinical considerations in early-onset cerebral amyloid angiopathy
Banerjee, G., Collinge, J., Fox, N. C., Lashley, T., Mead, S., Schott, J. M., Werring, D. J., & Ryan, N. S. (2023) · Brain · doi:10.1093/brain/awad193 · Cited by 54
Antonios, G., Saiepour, N., Bouter, Y., Richard, B. C., Paetau, A., Verkkoniemi-Ahola, A., Lannfelt, L., Ingelsson, M., Kovacs, G. G., Pillot, T., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-56 · Cited by 53
Self-citationKalimo, H., Lalowski, M. M., Bogdanović, N., Philipson, O., Bird, T. D., Nochlin, D., Schellenberg, G. D., Brundin, R., Olofsson, T., Soliymani, R., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-60 · Cited by 52
Self-citationProgressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model
Rönnbäck, A., Zhu, S., Dillner, K., Aoki, M., Lilius, L., Näslund, J., Winblad, B. G., & Graff, C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.021 · Cited by 47
Self-citationBi, C., Bi, S., & Li, B. (2018) · Aging and Disease · doi:10.14336/ad.2018.0425 · Cited by 46
Lord, A., Philipson, O., Klingstedt, T., Westermark, G. T., Hammarström, P., Nilsson, K. P. R., & Nilsson, L. N. G. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.052 · Cited by 46
Rönnbäck, A., Sagelius, H., Bergstedt, K. D., Näslund, J., Westermark, G. T., Winblad, B., & Graff, C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.07.012 · Cited by 43
Self-citationDissecting Alzheimer disease in Down syndrome using mouse models
Choong, X. Y., Tosh, J., Pulford, L. J., & Fisher, E. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00268 · Cited by 41
de la Vega, M. P., Giedraitis, V., Michno, W., Kilander, L., Güner, G., Zielinski, M., Löwenmark, M., Brundin, R., Danfors, T., Söderberg, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc6184 · Cited by 40
Self-citationRujeedawa, T., Félez, E. C., Clare, I. C. H., Fortea, J., Strydom, A., Rebillat, A., Coppus, A. M. W., Levin, J., & Zaman, S. H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194582 · Cited by 43
APP mutations in the Aβ coding region are associated with abundant cerebral deposition of Aβ38
Moro, M. L., Giaccone, G., Lombardi, R., Indaco, A., Uggetti, A., Morbin, M., Saccucci, S., Fede, G. D., Catania, M., Walsh, D. M., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1061-x · Cited by 39
Kawakatsu, S., Kobayashi, R., & Hayashi, H. (2017) · Neuropathology · doi:10.1111/neup.12364 · Cited by 39
Hereditary and Sporadic Forms of Aβ-Cerebrovascular Amyloidosis and Relevant Transgenic Mouse Models
Kumar‐Singh, S. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10041872 · Cited by 40
Kriaučiūnaitė, K., Kaušylė, A., Pajarskienė, J., Tunaitis, V., Lim, D., Verkhratsky, A., & Pivoriūnas, A. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00871-w · Cited by 40
Chen, Y., Wei, G., Nie, H., Lin, Y., Tian, H., Liu, Y., Yu, X., Cheng, S., Yan, R., Wang, Q., et al. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.005 · Cited by 38
Philipson, O., Lord, A., Lalowski, M. M., Soliymani, R., Baumann, M., Thyberg, J., Bogdanović, N., Olofsson, T., Tjernberg, L. O., Ingelsson, M., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.022 · Cited by 40
Self-citationAmyloid β in hereditary cerebral hemorrhage with amyloidosis-Dutch type
Kamp, J. A., Moursel, L. G., Haan, J., Terwindt, G. M., Lesnik Oberstein, S. A. M. J., van Duinen, S. G., & van Roon-Mom, W. M. C. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0008 · Cited by 36
Rammes, G., Mattusch, C., Wulff, M., Seeser, F., Kreuzer, M., Zhu, K., Deussing, J. M., Herms, J. W., & Parsons, C. G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.003 · Cited by 37
Andersson, E., Lindblom, N., Janelidze, S., Salvadó, G., Gkanatsiou, E., Söderberg, L., Möller, C., Lannfelt, L., Ge, J., Hanrieder, J., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00810-8 · Cited by 38
Self-citationSong, X., Hu, J., Sun, M., Li, Z. P., Wu, D. H., Ji, H.-L., Yuan, Y., Zhu, Z., Han, N., Liu, G., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.049 · Cited by 30
11C-PiB PET can underestimate brain amyloid-β burden when cotton wool plaques are numerous
Abrahamson, E. E., Kofler, J., Becker, C. R., Price, J. C., Newell, K. L., Ghetti, B. F., Murrell, J. R., McLean, C., López, O. L., Mathis, C. A., et al. (2021) · Brain · doi:10.1093/brain/awab434 · Cited by 28
Main features of hereditary cerebral amyloid angiopathies: A systematic review
Biffi, A. (2022) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2022.100124 · Cited by 30
What is ‘early onset dementia’?
Miyoshi, K. (2009) · Psychogeriatrics · doi:10.1111/j.1479-8301.2009.00274.x · Cited by 36
Guzmán, E. A., Bouter, Y., Richard, B. C., Lannfelt, L., Ingelsson, M., Paetau, A. E., Verkkoniemi‐Ahola, A., Wirths, O., & Bayer, T. A. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-13 · Cited by 27
Self-citationNew Genes and New Insights from Old Genes
Ringman, J. M., & Coppola, G. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000429179.21977.a1 · Cited by 27
Cerebrovascular disorders associated with genetic lesions
Karschnia, P., Nishimura, S., & Louvi, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2934-5 · Cited by 25
Anti-amyloid Antibody Therapies for Alzheimer’s Disease
Park, K. W. (2024) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-024-00848-3 · Cited by 25
Genetic Animal Models of Cerebral Vasculopathies
Lee, J. H., Bacskai, B. J., & Ayata, C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00002-0 · Cited by 21
Lemoine, L., Gillberg, P., Bogdanović, N., Nennesmo, I., Saint‐Aubert, L., Viitanen, M. H., Graff, C., Ingelsson, M., & Nordberg, A. K. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0817-2 · Cited by 23
Self-citationPeripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
Nelson, A. R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.858429 · Cited by 24
The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis
Nostrand, W. E. V. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.020 · Cited by 22
Schilling, S., Pradhan, A., Heesch, A., Helbig, A., Blennow, K., Koch, C., Bertgen, L., Koo, E. H., Brinkmalm, G., Zetterberg, H., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01577-y · Cited by 21
NMR structure of the Arctic mutation of the Alzheimer’s Aβ(1–40) peptide docked to SDS micelles
Usachev, K. S., Filippov, A. V., Khairutdinov, B. I., Antzutkin, O. N., & Klochkov, V. V. (2014) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2014.08.030 · Cited by 20
Almkvist, O., Rodriguez‐Vieitez, E., Þórðardóttir, S., Amberla, K., Axelman, K., Basun, H., Ståhlbom, A. K., Lilius, L., Remes, A. M., Wahlund, L., et al. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617716001028 · Cited by 19
Self-citationArctic mutant Aβ40 aggregates on α7 nicotinic acetylcholine receptors and inhibits their functions
Ju, Y., Asahi, T., & Sawamura, N. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12837 · Cited by 17
Brain-targeted nanoparticles to overcome the blood-brain barrier
Seko, I., ŞAHİN, A., Tonbul, H., & Çapan, Y. (2020) · Journal of Pharmaceutical Technolgy · doi:10.37662/jpt.2020.4 · Cited by 16
Noguchi‐Shinohara, M., Shuta, K., Murakami, H., Mori, Y., Komatsu, J., Kobayashi, C., Hersch, S. M., Horie, K., & Ono, K. (2025) · Annals of Neurology · doi:10.1002/ana.27175 · Cited by 16
Illes‐Toth, E., Meisl, G., Rempel, D. L., Knowles, T. P. J., & Gross, M. L. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00072 · Cited by 15
Singh, P. K., Badimon, A., Chen, Z., Strickland, S., & Norris, E. H. (2021) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12504 · Cited by 17
Uras, G., Manca, A., Zhang, P., Markus, Z., Mack, N. A., Allen, S., Bo, M., Xu, S., Xu, J., Γεωργίου, Μ., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.691222 · Cited by 14
Tehrani, M. J., Matsuda, I., Yamagata, A., Kodama, Y., Matsunaga, T., Sato, M., Toyooka, K., McElheny, D., Kobayashi, N., Shirouzu, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51294-w · Cited by 14
Saini, R. K., Shuaib, S., Goyal, D., & Goyal, B. (2020) · ACS Omega · doi:10.1021/acsomega.0c02983 · Cited by 11
Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer’s Disease
Wheeler, K. V., Andrei Irimia, A., & Braskie, M. N. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230553 · Cited by 9
Attar, A., Meral, D., Urbanc, B., & Bitan, G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00038-9 · Cited by 9
Klingstedt, T., Shirani, H., Parvin, F., Nyström, S., Hammarström, P., Graff, C., Ingelsson, M., Vidal, R., Ghetti, B. F., Sehlin, D., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108032 · Cited by 8
Self-citationOh, S., Kim, S., Lee, J., Park, B., Won, J. H., & Park, H. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103660 · Cited by 7
Hark, T. J., & Savas, J. N. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15298 · Cited by 7
Τhe Greek Variant in APP Gene: The Phenotypic Spectrum of APP Mutations
Kalampokini, S., Georgouli, D., Patrikiou, E., Provatas, A., Valotassiou, V. J., Georgoulias, P., Spanaki, C., Hadjigeorgiou, G. M., & Xiromerisiou, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212355 · Cited by 7
Distinct cerebral amyloid angiopathy patterns in adult Down syndrome
Szalárdy, L., Lee, S., Kim, A., & Kovács, G. G. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123601 · Cited by 6
Ju, Y., Asahi, T., & Sawamura, N. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.09.005 · Cited by 6
Liu, Y., Xiao, X., Liu, H., Liao, X., Zhou, Y., Weng, L., Zhou, L., Liu, X., Bi, X., Xu, T., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1013295 · Cited by 8
Ringman, J. M., Teplow, D. B., & Villemagne, V. L. (2012) · Neurology · doi:10.1212/wnl.0b013e31825fe11f · Cited by 6
Hunter, S., Walsh, S., & Brayne, C. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03156-0 · Cited by 7
Generation of Amyloid‐β Peptides by γ‐Secretase
Aguayo‐Ortiz, R., & Domı́nguez, L. (2016) · Israel Journal of Chemistry · doi:10.1002/ijch.201600073 · Cited by 4
Aβ Imaging in Aging, Alzheimer’s Disease and Other Neurodegenerative Conditions
Villemagne, V. L., Fodero‐Tavoletti, M. T., Yates, P. A., Masters, C. L., & Rowe, C. C. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_10 · Cited by 4
Familial cerebral amyloid disorders with prominent white matter involvement
Banerjee, G., Schott, J. M., & Ryan, N. S. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-99209-1.00010-7 · Cited by 3
Functional efficacy of tempeh oil microemulsion containing omega 3 for Alzheimer’s protection
Yanti, Y., Maha, V., Subali, D., & Tjandrawinata, R. R. (2023) · Food Research · doi:10.26656/fr.2017.7(6).977 · Cited by 2
Ni, R. (2015) · Figshare · Cited by 2
Predicting Cognitive Decline in Older Adults Through Multi-Voxel Pattern Analysis
Hantke, N. C. (2014) · e-Publications@Marquette (Marquette University) · Cited by 2
Modeling Amyloid Disease in Drosophila melanogaster
Berg, I. (2010) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
What caused this intracerebral hemorrhage?
Radmanesh, F., & Rosand, J. M. (2019) · Wiley eBooks · doi:10.1002/9781118492390.ch8 · Cited by 1
The Alzheimer disease continuum : findings from monogenic Alzheimer disease
Johansson, C. (2025) · doi:10.69622/28639856 · Cited by 3
Targeting Early Stages of Alzheimer’s Disease in a Transgenic Model
Lord, A. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
[Rare mutations aim toward future treatment].
Ingelsson, M., Basun, H., Pettersson, F. E., Kilander, L., Nilsson, L. N. G., & Lannfelt, L. (2009) · PubMed
Self-citationAmyloid precursor protein with the Alzheimer´s disease 670/671 mutation : Animal and cellular models
Kloskowska, E. (2008) · Figshare
Metadata
- Authors
- Basun, H., Bogdanovic, N., Ingelsson, M., Almkvist, O., Näslund, J., Axelman, K., Bird, T. D., Nochlin, D., Schellenberg, G. D., Wahlund, L.-O., & Lannfelt, L.
- Affiliations
- Karolinska Institutet (SE)
- Uppsala University (SE)
- Stockholm University (SE)
- University of Washington (US)
- ORCID
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2008-04-01
- Volume
- 65
- Issue
- 4
- Pages
- 499
- ISSN
- 0003-9942 (ISSN-L)
- PMC
- PMC2723757
- OpenAlex
- W2126866809
- Cited by
- 115
- References
- 26
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 8 · 2023: 5 · 2022: 6 · 2021: 9 · 2020: 6 · 2019: 3 · 2018: 3 · 2017: 7 · 2016: 3 · 2015: 4 · 2014: 10 · 2013: 6 · 2012: 10
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (P50AG005136)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- amyloid precursor protein, early-onset Alzheimer's disease, familial Alzheimer's disease, intracerebral hemorrhage, cognitive impairment, brain atrophy, cerebral amyloid angiopathy, neurofibrillary tangles, amyloid plaques, neuropathology
- MeSH terms
- Age Factors, Aged, Alzheimer Disease, Atrophy, Brain, Child, Electroencephalography, Female, Genotype, Genetic Carrier Screening, Humans, Magnetic Resonance Imaging, Middle Aged, Neurologic Examination, Neuropsychological Tests, Parietal Lobe, Pedigree, Phenotype, Receptors, Cell Surface, Regional Blood Flow, Sweden, United States, Tomography, Emission-Computed, Single-Photon, Amyloid beta-Protein Precursor, Age of Onset, Plaque, Amyloid, Protease Nexins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
